ong term follow up after rotationplasty

Recruiting

Conditions: Osteosarcoma, Ewingsarcoma, Chondrosarcoma, Giant cell tumor, Synoviosarcoma, Proximal focal femoral deficiency

Registration Number: NL-OMON25651

Lead Sponsor: St. Lodewijk- de Kort and the Dpt. of Orthopedic surgery Amsterdam UMC (AMC)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 70

Inclusion Criteria

·Treated with a rotationplasty for primary malignant bone tumours or PFFD at the AMC or at the OLVG in Amsterdam between 1980-2005.
·Being able to visit the AMC in Amsterdam once or twice.

Exclusion Criteria

·To perform the walking energy cost measurements, patients need to walk 6 minutes. If they cannot maintain 6 minutes of walking, they are only excluded for that part of the study.
·Patients who cannot read and/ or write Dutch cannot participate the study.
·Patients with contra-indications for radiographs will be exempted to this part of the study.

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To asses health-related quality of life and functional outcome after long-term follow up, in patients treated with a rotationplasty for primary malignant bone tumours or PFFD compared to above-knee amputation means for similar indications.

Secondary Outcome Measures

Name	Time	Method
·To evaluate factors affecting health-related quality of life, occupation and sport activities with regard to the performed rotationplasty.<br>·To measure self-reported activity limitations of these patients by questionnaire’s and satisfaction with their external prosthesis. And to further objectify activity limitations after rotationplasty, as measured by gait biomechanics, walking speed and walking energy cost.<br>·Furthermore, impairments will be revealed by physical examination of hips, knee and ankles objectified by development of osteoarthritis on plain radiographs.<br>